Jones Financial Companies Lllp Buys 19,628 Shares of Centene Corporation $CNC

Jones Financial Companies Lllp lifted its stake in shares of Centene Corporation (NYSE:CNC) by 222.7% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 28,441 shares of the company’s stock after acquiring an additional 19,628 shares during the period. Jones Financial Companies Lllp’s holdings in Centene were worth $991,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Mowery & Schoenfeld Wealth Management LLC bought a new stake in Centene during the third quarter worth approximately $27,000. WPG Advisers LLC boosted its holdings in shares of Centene by 44.5% during the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after buying an additional 282 shares during the period. Bogart Wealth LLC grew its stake in Centene by 11,011.1% in the 3rd quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock valued at $36,000 after buying an additional 991 shares during the last quarter. Financial Network Wealth Advisors LLC raised its holdings in Centene by 54.9% in the 3rd quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock worth $39,000 after acquiring an additional 390 shares during the period. Finally, Assetmark Inc. lifted its position in Centene by 248.2% during the 2nd quarter. Assetmark Inc. now owns 1,156 shares of the company’s stock worth $63,000 after acquiring an additional 824 shares during the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Centene Stock Up 2.1%

Shares of CNC stock opened at $40.43 on Thursday. The stock has a market cap of $19.87 billion, a P/E ratio of -2.97, a price-to-earnings-growth ratio of 0.87 and a beta of 0.48. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.10 and a quick ratio of 1.08. The stock has a fifty day moving average price of $42.08 and a 200 day moving average price of $36.18. Centene Corporation has a one year low of $25.08 and a one year high of $66.03.

Centene (NYSE:CNC) last released its quarterly earnings data on Friday, February 6th. The company reported ($1.19) EPS for the quarter, topping analysts’ consensus estimates of ($1.22) by $0.03. The company had revenue of $49.73 billion during the quarter, compared to the consensus estimate of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The firm’s revenue for the quarter was up 21.9% compared to the same quarter last year. During the same period last year, the firm earned $0.80 EPS. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Analysts predict that Centene Corporation will post 6.86 earnings per share for the current year.

Centene News Summary

Here are the key news stories impacting Centene this week:

• Positive Sentiment: Zacks/MSN published pieces arguing Centene is a long‑term value stock, highlighting attractive valuation metrics and the company’s scale in government-sponsored health plans; this kind of favorable narrative can support investor demand. Read More. Read More.
• Positive Sentiment: Centene’s community outreach via Superior HealthPlan and The Centene Foundation (No One Eats Alone program in Texas schools) is positive for brand and ESG perception—helps long‑term reputation with payors and state partners. Read More.
• Positive Sentiment: Deutsche Bank raised its price target to $39 (from $32) and kept a Hold rating—an upward revision that signals modestly improved analyst expectations even if the rating stayed conservative. Read More.
• Positive Sentiment: TD Cowen also raised its target to $38 (from $34) and maintained a Hold—another incremental upgrade to analyst targets that can support the stock after recent volatility. Read More.
• Neutral Sentiment: Argus moved Centene to a Hold—an analyst change that reduces downside concern but is not a clear buy signal. Read More.
• Neutral Sentiment: Cantor Fitzgerald reaffirmed a Neutral rating, keeping consensus sentiment cautious given regulatory and margin pressures. Read More.
• Neutral Sentiment: Morgan Stanley maintained its Hold on Centene, consistent with the mixed analyst tone—supportive of stability but not a catalyst for a large rerating. Read More.
• Negative Sentiment: Axios/other outlets report Centene is among insurers to receive subpoenas from a House panel—this introduces regulatory and legal risk that could pressure sentiment and create short‑term volatility. Read More.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on CNC shares. TD Cowen lifted their price objective on Centene from $34.00 to $38.00 and gave the stock a “hold” rating in a research note on Wednesday. Oppenheimer reaffirmed an “outperform” rating and issued a $45.00 price target on shares of Centene in a research report on Thursday, October 30th. Argus raised Centene to a “hold” rating in a research report on Monday. Zacks Research upgraded shares of Centene from a “strong sell” rating to a “hold” rating in a research note on Wednesday, October 29th. Finally, The Goldman Sachs Group restated a “sell” rating and issued a $38.00 price target (up from $33.00) on shares of Centene in a research report on Thursday, October 30th. Three investment analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, Centene currently has an average rating of “Hold” and a consensus price target of $41.50.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.